Carlo Viscomi

Carlo Viscomi’s research focuses on inherited diseases that affect mitochondria, often lacking available treatments. His laboratory has uncovered new mechanisms underlying these conditions, such as the accumulation of toxic substances in some severe forms, and has contributed to developing pharmacological therapies now used in clinical practice. Moreover, he has developed gene therapy techniques to correct defects in animal models, paving the way for future patient treatments. He also studies how to increase the production of new mitochondria and how to modify them to function more effectively. His goal is to translate laboratory discoveries into concrete and innovative therapies.